Circadian rhythms are intrinsic, entrainable oscillations of about 24 h in behavior, metabolism, and physiology found in almost all living organisms. This internal clock allows organisms to synchronize their physiology and behavior with the predictable cycle of day and night. Disruption of normal circadian rhythms leads to clinically relevant disorders, including neurodegeneration, diabetes, obesity, and cardiovascular disease ([@r1][@r2][@r3]--[@r4]). In mammals, the core circadian circuit composed of transcriptional activators and repressors that form an autoregulatory transcriptional feedback loop is necessary for the generation and regulation of circadian rhythms with an endogenous period close to 24 h. The bHLH-PAS transcription factors (TFs) CLOCK and BMAL1 are heterodimeric transcriptional activators that drive the expression of *Period* genes (*Per1*, *Per2*, and *Per3*) and *Cryptochrome* genes (*Cry1* and *Cry2*), by binding E-box cis-regulatory elements at promoters ([@r5][@r6][@r7][@r8]--[@r9]). Subsequently, the PER--CRY protein complex inhibits transcription of its own genes by directly inhibiting CLOCK:BMAL1 activity ([@r8], [@r10][@r11][@r12]--[@r13]). This feedback loop has been known as the critical hub of the mammalian oscillator.

While many mammalian peripheral tissues have circadian clocks, genes showing circadian expression are markedly diverse within individual tissues of mouse or human, indicating tissue-specific regulation of circadian output relevant to the function of the particular organ ([@r14][@r15][@r16][@r17]--[@r18]). The core clock may be regulated in a tissue-specific manner as well, supported by observations that explants of diverse mouse tissues express differences in circadian period and phase ([@r16]), and that output networks must be driven by the core clock components in a cell type-specific manner. However, such tissue-specific factors responsible for robust tissue-specific circadian rhythmicity remain to be identified.

The nuclear receptor (NR) superfamily is composed of 48 members in human. NRs coordinate processes as diverse as development, reproduction, and many aspects of metabolism. As sensors for lipophilic vitamins, hormones, and dietary lipids, NRs canonically function as ligand-activated transcription factors that regulate the expression of their target genes to affect physiological pathways ([@r19]). The importance of NRs in maintaining optimal physiological homeostasis is illustrated in their identification as potential targets for therapeutic drug development to combat a diverse array of diseases, including reproductive disorders, inflammation, cancer, diabetes, cardiovascular disease, and obesity ([@r20]). Various NRs have been implicated as targets of the circadian clock, which may contribute to the circadian regulation of nutrient and energy metabolism. Over half of the NR family members are expressed in a rhythmic manner ([@r21]). Further, PER2 and CRYs were found to broadly interact with NRs and potentially modulate their transcriptional activity ([@r22][@r23][@r24]--[@r25]).

Apart from the circadian control of NR expression and transcriptional activity, other direct links between NR activity and circadian clock function have been identified via NRs' role as circadian clock inputs. In addition to functions in development, metabolism, and immunity, the nuclear receptors REV-ERBs and retinoic acid receptor-related orphan receptors (RORs) constitute the secondary feedback loop in the circadian cycle, by directly repressing and activating *Bmal1* expression, respectively, and in turn being transcriptionally regulated by CLOCK:BMAL1 ([@r26][@r27][@r28]--[@r29]). Dysregulation of REV-ERBs and RORs have dramatic effects on the robustness of circadian oscillators ([@r30][@r31][@r32][@r33]--[@r34]). However, little is known as to whether other NRs are involved in the regulation of core clock parameters.

The nuclear receptor hepatocyte nuclear factor 4A (HNF4A) binds as a homodimer to the consensus DNA sequence consisting of two direct repeats and controls the expression of downstream genes ([@r35]). It is expressed in a tissue-specific manner and plays essential roles in the development and physiology of liver, pancreas, kidney, and intestines, particularly lipid and glucose metabolism and inflammation ([@r36][@r37][@r38][@r39][@r40][@r41]--[@r42]). In the current study, we demonstrate that HNF4A potently inhibits the transcriptional activity of CLOCK:BMAL1 heterodimer. Furthermore, our data clearly show that HNF4A is necessary for the regulation of intrinsic circadian oscillations in liver and colon cells, suggesting its role in regulating tissue-specific clock networks.

Results {#s1}
=======

Identification of HNF4A as a CLOCK:BMAL1 Transrepressor. {#s2}
--------------------------------------------------------

The growing body of evidence demonstrating a link between nuclear receptors, metabolic pathways, and intrinsic circadian rhythmicity ([@r21][@r22][@r23][@r24]--[@r25]) prompted us to test the potential for a broader range of nuclear receptors in mediating this cross-talk. In a physical interaction profiling, we noted a robust binding between core clock proteins and the HNF4A protein, as shown in coimmunoprecipitation experiments using either recombinant or endogenous proteins ([Fig. 1 *A--C*](#fig01){ref-type="fig"}). To evaluate the biological significance of the interactions, we hypothesized that either the core clock components regulate the activity of nuclear receptor HNF4A, or HNF4A may transduce metabolic signals as inputs to the circadian system. To test the first hypothesis, we conducted a reporter assay in HEK 293T cells using a luciferase reporter driven by tandem HNF4A consensus binding motifs. Neither CRY1 nor CLOCK:BMAL1 coexpression affected the HNF4A transcriptional activity, indicating that HNF4A activity is unlikely to be directly regulated by these clock proteins ([*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)).

![HNF4A physically interacts with the core clock complex and transsuppresses the transcriptional activity of CLOCK:BMAL1. (*A*) Coimmunoprecipitation of transiently expressed core clock proteins and HNF4A from HEK 293T extract. (*B* and *C*) Coimmunoprecipitation of endogenous BMAL1 (*B*) or CRY1 (*C*), and HNF4A from HepG2 extract. (*D*--*F*) HNF4A inhibits CLOCK:BMAL1 activity in luminescent reporter assays. HEK 293T cells were cotransfected with reporter gene *E-box-dLuc* (*D*), *Per2-dLuc* (*E*), or *Per1-Luc* (*F*), CLOCK:BMAL1, and increasing amounts of EGFP, CRY1, or HNF4A plasmid (*n* = 3 for each condition, mean ± SD).](pnas.1816411115fig01){#fig01}

We then tested the second hypothesis, asking whether the core clock feedback loops are regulated by the HNF4A protein. As HNF4A consistently binds CLOCK:BMAL1, we evaluated the effect of HNF4A on CLOCK:BMAL1 activity in endpoint reporter assays using the *E-box-dLuc*, *Per1-Luc*, or *Per2-dLuc* luciferase reporters. Surprisingly, we observed a consistent inhibition of CLOCK:BMAL1 activity by HNF4A coexpression in a dose-dependent pattern (*P* \< 0.05), similar to the canonical clock repressor CRY1 ([Fig. 1 *D--F*](#fig01){ref-type="fig"}). Collectively, these findings indicate activity of the nuclear receptor HNF4A in transrepressing another transcription factor CLOCK:BMAL1 and prompted us to evaluate its role in the intact molecular circadian oscillators.

HNF4A Is Essential for Tissue-Specific Rhythm Maintenance and Period Regulation. {#s3}
--------------------------------------------------------------------------------

As HNF4A is minimally expressed in bone osteosarcoma U2OS cells, our previous genome-wide RNAi screen ([@r43]) was unable to assess its potential as a clock modifier ([*SI Appendix*, Fig. S2](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). We therefore screened cell lines isolated from various tissue types to identify ones that both express a high level of HNF4A and oscillate upon dexamethasone synchronization. The cell lines we eventually identified are human liver cells Hep3B, mouse liver cells dihXY, and human colon cells SW480, which were genetically modified to stably express *Per2-dLuc* or *Bmal1-Luc* reporter gene. To assess the role of HNF4A in regulating circadian oscillations of these cells, we performed gene knockdown by using *Hnf4a* or *Cry1* siRNAs ([@r43]) selected for their potency (of ∼80%) ([*SI Appendix*, Fig. S3 *A*--*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). Surprisingly, the effect of *Hnf4a* knockdown in both liver cell lines Hep3B and dihXY was even more disruptive than *Cry1* knockdown, leading to arrhythmicity ([Fig. 2 *A--D*](#fig02){ref-type="fig"}). The *Hnf4a* knockdown has a negative effect on the growth of SW480 colon cells, which is reflected by dampened amplitude of *Per2-dLuc* ([*SI Appendix*, Fig. S3*D*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). We subtracted the baseline trends, to better visualize the bioluminescence traces, and found that the effect of *Hnf4a* knockdown on the circadian rhythm was milder and resulted in period shortening by roughly 1 h ([Fig. 2 *E* and *F*](#fig02){ref-type="fig"}), similar to the *Cry1* knockdown ([*SI Appendix*, Fig. S3 *E* and *F*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). The cell type-specific phenotypes of *Hnf4a* knockdown are consistent with previous observations for other clock genes ([@r44]).

![HNF4A is critical for circadian rhythm maintenance and period regulation in liver and colon cells. (*A*) Representative effect of control scramble, *Cry1*, or *Hnf4a* siRNA on *Bmal1-Luc* reporter in human liver cells Hep3B (*n* = 5). (*B*) Mean period of circadian luminescence rhythms in *A*. Data are represented as mean ± SD (*n* = 5). (*C*) Representative effect of control scramble, *Cry1*, or *Hnf4a* siRNA on *Bmal1-Luc* reporter in mouse liver cells dihXY (*n* = 5). (*D*) Mean period of circadian luminescence rhythms in *C*. Data are represented as mean ± SD (*n* = 5). Significance between scramble siRNA and *Cry1* siRNA was assessed by Student's *t* test, *P* = 7.75e-05 (\<0.05). (*E*) Representative effect of control scramble or *Hnf4a* siRNA on *Per2-dLuc* reporter in human colon cells SW480 (*n* = 3). (*F*) Mean period of circadian luminescence rhythms in *E*. Data are represented as mean ± SD (*n* = 3). Significance was assessed by Student's *t* test, *P* = 4.72e-03 (\<0.05). (*G*) Representative effect of expressing EGFP or HNF4A on *Per2-dLuc* reporter in U2OS cells. (*H*) Mean period of circadian luminescence rhythms in *G*. Data are represented as mean ± SD (*n* = 16). Significance between EGFP and HNF4A expression was assessed by Student's *t* test, *P* = 1.91e-05 (\<0.05).](pnas.1816411115fig02){#fig02}

Using U2OS *Per2-dLuc* cells, we generated stable lines expressing EGFP, CRY1, PER2, or HNF4A. Additional expression of CRY1 and PER2 proteins led to arrhythmicity along with greatly reduced *Per2-dLuc* reporter signals ([*SI Appendix*, Fig. S3*G*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). In contrast, ectopic expression of the *Hnf4a* gene significantly dampened the amplitude and lengthened the period ([Fig. 2 *G* and *H*](#fig02){ref-type="fig"}). Taken together, our data suggest that HNF4A is essential for circadian rhythmicity of cells where it is endogenously expressed and significantly alters the intrinsic circadian clock when ectopically expressed. We thus identify HNF4A to be a central regulator of tissue-specific circadian rhythms in liver and colon cell lines.

HNF4A Acts Differently from Other CLOCK:BMAL1 Repressors. {#s4}
---------------------------------------------------------

As HNF4A is able to bind CRY proteins as well ([Fig. 1 *A* and *C*](#fig01){ref-type="fig"}), we asked whether its CLOCK:BMAL1 repression is attributable to an indirect mechanism bridged by CRYs. We applied the CLOCK HI:BMAL1 LL/AA mutant which can no longer be sequestered by CRY1 ([@r45], [@r46]). Even though the activation of *Per1-Luc* reporter by CLOCK HI:BMAL1 LL/AA mutant is less pronounced than the wild-type complex, our results show that CRY1 repression was substantially abolished ([Fig. 3*A*](#fig03){ref-type="fig"}). In contrast, HNF4A could still prominently suppress the mutant complex, suggesting that HNF4A inhibits CLOCK:BMAL1 by a mechanism independent of CRY1 ([Fig. 3*B*](#fig03){ref-type="fig"}). This conclusion was further supported by our observation that the knockdown of two *Cry* genes ([@r43]) did not affect the extent of HNF4A-dependent repression of CLOCK:BMAL1 activity ([*SI Appendix*, Fig. S4*A*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)).

![HNF4A targets CLOCK:BMAL1 differently from CRY1. (*A* and *B*) HNF4A is able to suppress a CLOCK:BMAL1 mutant which interferes with sequestration by CRY1. HEK 293T cells were cotransfected with reporter gene *Per1-Luc*, wild-type or mutant CLOCK:BMAL1, and increasing amounts of CRY1 (*A*) or HNF4A (*B*) plasmid (*n* = 3 for each condition, mean ± SD). Percentages on the *Top* indicate the degree of CLOCK:BMAL1 repression.](pnas.1816411115fig03){#fig03}

Apart from CRYs, other protein--protein interaction dependent CLOCK:BMAL1 repressors have recently emerged as key regulators of the circadian networks, e.g., CHRONO, DEC1/2, and PASD1 ([@r47][@r48][@r49]--[@r50]). Cancer/testis antigen PASD1 was identified to repress the CLOCK:BMAL1 activity depending upon exon 19 of the *Clock* gene ([@r47]). Deletion of exon 19 was found to attenuate the transactivation potential of the transcription factor ([@r6], [@r7]). We found that HNF4A could still potently repress the residual activity of the CLOCK^Δ19^:BMAL1 complex ([*SI Appendix*, Fig. S4*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). Consequently, there appears to be a different targeting mechanism leveraged by HNF4A in achieving CLOCK:BMAL1 repression activity.

Multiple HNF4A Domains Are Involved in CLOCK:BMAL1 Repression. {#s5}
--------------------------------------------------------------

Like most other nuclear receptors, HNF4A contains six structural domains that are necessary to mediate disparate functions: an N-terminal activation function (AF)‐1 domain; a DNA-binding domain (DBD); a putative ligand-binding domain (LBD); a flexible hinge between the DBD and LBD; a C-terminal activation domain (AF-2), and a repressor region (F domain) that recruits corepressors and inhibits access of coactivators to AF-2 ([@r51][@r52][@r53][@r54][@r55]--[@r56]). We used various genetic tools to characterize the transrepression activity of HNF4A. The predominant HNF4A splice variants, HNF4A1, HNF4A2, and HNF4A8, driven by tissue-specific promoters P1 or P2, are considered to have different physiological roles in development and transcriptional regulation of target genes. P1-driven HNF4A1 and HNF4A2, which differ exclusively by 10 amino acids in the F domain, are specifically expressed in the adult liver and kidney; whereas the P2-driven HNF4A8 is not found in these tissues but in fetal liver and the adult pancreas. Relative to HNF4A1/2, HNF4A8 lacks the N-terminal activation domain AF‐1 ([@r57][@r58]--[@r59]). We further tested the effect of HNF4G, which shares nearly identical DBD and LBD domains with HNF4A. Intriguingly, all HNF4A isoforms we tested, together with HNF4G, potently repressed CLOCK:BMAL1 activity ([Fig. 4*A*](#fig04){ref-type="fig"}). It suggests that the HNF4 proteins share a common transrepression activity in various peripheral tissues where they are specifically expressed, and the unshared structural domains or protein sequences are dispensable for the activity. To explore contribution of some major functional domains, we generated constructs expressing HNF4A2 fragments. We found that deletion of the AF-1 and DBD domains (Δ 1--119), LBD (Δ 137--365), or the F domain (amino acids 1--376) did not decrease the protein expression ([*SI Appendix*, Fig. S5](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)) but substantially abolished an efficient repression of the CLOCK:BMAL1 activity ([Fig. 4*B*](#fig04){ref-type="fig"}). To potently transrepress the CLOCK:BMAL1 transcriptional activity, our data reflect requirements of the DBD, LBD, and F domains within the intact HNF4 protein.

![Multiple HNF4A functional domains are required for CLOCK:BMAL1 transrepression. (*A*) HNF4A isoforms and HNF4G repress CLOCK:BMAL1 activity similarly. HEK 293T cells were cotransfected with reporter gene *Per1-Luc*, CLOCK:BMAL1, and increasing amounts of HNF4 plasmid (*n* = 3 for each condition, mean ± SD). (*B*) Domain analysis of HNF4A2. HEK 293T cells were cotransfected with reporter gene *Per1-Luc*, CLOCK:BMAL1, and increasing amounts of HNF4A2 fragment plasmid (*n* = 3 for each condition, mean ± SD).](pnas.1816411115fig04){#fig04}

HNF4A mRNA Level and Chromatin Binding Are Rhythmic in Mouse. {#s6}
-------------------------------------------------------------

Our combined data suggest that HNF4A shares many of the canonical properties of a core clock protein ([@r60]). We further examined *Hnf4a* mRNA expression in liver, pancreas, and colon of C57BL/6J mice over a light/dark (LD) cycle, and found it to be rhythmic on a 24-h timescale, with a cyclic pattern (peak at night) and modest but detectable amplitude comparable to the *Cry2* gene (SAS PROC ANOVA, *P* \< 0.001, [Fig. 5](#fig05){ref-type="fig"}). HNF4A has been known to play central roles in dietary lipid absorbance, bile acid synthesis, conjugation, and transport ([@r38], [@r61][@r62]--[@r63]). However, the accumulation of HNF4A transcripts in the early evening is unlikely to be induced by diet, as mice that are normally fed and fasted have similar levels of *Hnf4a* transcript at zeitgeber time 14 (ZT14), in contrast to the remarkable differences in gluconeogenic genes *Pck1* and *G6pc* ([*SI Appendix*, Fig. S6](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). By analyzing ChIP-seq data ([@r64]), we observed binding of CLOCK, BMAL1, and CRYs at the *Hnf4a* gene ([*SI Appendix*, Fig. S7](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)), suggesting that *Hnf4a* transcription is directly modulated by the core clock proteins.

![Gene *Hnf4a* is rhythmically expressed in vivo. Mouse liver (*A*), pancreas (*B*), and colon (*C*) were harvested at 4-h intervals over the course of 24 h. Transcript levels were analyzed by using RT-qPCR. Displayed are the means ± SD (*n* = 5 mice) normalized to nonoscillating *Rplp0* expression levels.](pnas.1816411115fig05){#fig05}

To address whether the HNF4A functions are also rhythmically regulated, we used chromatin immunoprecipitation to evaluate its genome-wide binding at ZT4 and ZT16 in the mouse liver, which correspond to the trough and peak of *Hnf4a* transcript abundance. Surprisingly, out of 20,230 sites identified at ZT16, 17,839 are differentially occupied by HNF4A at ZT4, when only 6,163 peak sites were identified using the same cutoff ([Fig. 6*A*](#fig06){ref-type="fig"}). Consistently, genome-wide HNF4A occupancy is clearly more extensive at ZT16 compared with ZT4 ([Fig. 6*B*](#fig06){ref-type="fig"}). In particular, we observed strong rhythmicity of HNF4A binding at genes involved in well-characterized HNF4A-regulated processes ([*SI Appendix*, Fig. S8](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). HNF4A induces the expression of *Hnf1a*, another tissue-specific transcription factor that plays essential roles in key developmental processes ([@r65]). HNF4A is also required for bile acid synthesis by directly targeting *Cyp7a1* ([@r63], [@r66]) and is required for the expression of the xenobiotic nuclear receptor PXR (NR1I2) ([@r67]). Indeed, all of the three target genes show oscillating expression in the mouse liver with phases similar to *Hnf4a*, by exhibiting higher levels during the night ([*SI Appendix*, Fig. S9](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental), data derived from the CircaDB database) ([@r68]). In aggregate, our data strongly suggest that the oscillation of tissue-specific nuclear receptor HNF4A directly determines the rhythmicity of an array of its target genes, such that temporal regulation of various aspects of physiology can be achieved.

![The genome-wide chromatin binding of HNF4A is rhythmic and broadly overlaps with that of CLOCK:BMAL1 in the mouse liver. (*A*) Heatmap views of genome-wide binding of HNF4A at ZT4 and ZT16, measured over 2-kb fragments flanking each peak. Peaks are ordered vertically by signal strength, represented by the green-blue gradient. (*B*) Metaplot comparing genome-wide HNF4A-binding intensity at ZT4 and ZT16. (*C*) Chow--Ruskey diagram showing genome-wide cooccupancy of BMAL1, CLOCK, and HNF4A. An overlap was called when peaks overlap by \>1 bp. The boundaries for each protein are color coded: BMAL1 (blue), CLOCK (green), and HNF4A (red). The areas of each domain are proportional to the number of binding sites. (*D*) Pie chart showing the distribution of E-box and HNF4A consensus motifs at BMAL1--CLOCK--HNF4A cooccupied peaks. (*E*) Metaplot comparing HNF4A-binding intensity at loci with and without CLOCK:BMAL1 cooccupancy.](pnas.1816411115fig06){#fig06}

Notably, some phosphorylation events in HNF4A protein were also rhythmic, peaking around ZT15 ([@r69]). It will be of interest to investigate whether the rhythmic chromatin binding also involves a posttranslational mechanism, apart from the rhythmicity in mRNA level.

HNF4A and CLOCK:BMAL1 Cooccupy Clock and Metabolic Genes. {#s7}
---------------------------------------------------------

To assess the genome-wide effects of HNF4A-mediated CLOCK:BMAL1 transrepression, we compared cistromes of HNF4A (ZT16), BMAL1 (ZT8), and CLOCK (ZT8) ([@r64]) and calculated their overlaps. At the center of the Chow--Ruskey plot, 1,911 loci in the genome are bound by all three factors ([Fig. 6*C*](#fig06){ref-type="fig"}). Motif analysis of the common binding sites shows a significant enrichment for the canonical CLOCK:BMAL1 E-box motif (CACGTG) and HNF4A-binding motif ([*SI Appendix*, Fig. S10*A*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). Interestingly, only 40% of the cooccupied peaks have the two most abundant motifs identified ([Fig. 6*D*](#fig06){ref-type="fig"}), with several essential signaling pathways differentially overrepresented in four motif categories ([*SI Appendix*, Fig. S10*C*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). Furthermore, the HNF4A binding was stronger at loci cooccupied by CLOCK:BMAL1 relative to the HNF4A-exclusive binding sites ([Fig. 6*E*](#fig06){ref-type="fig"}). These results indicate that HNF4A and CLOCK:BMAL1 broadly interact at their cooccupied genomic loci, and a tethering mechanism may be involved in their coregulation of target gene transcription. Gene Ontology analysis of genes commonly occupied by the two transcription factors shows enrichment for circadian circuits, as well as pathways regulating lipid, glucose, and amino acid metabolism ([*SI Appendix*, Fig. S10*B*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). Hence, apart from the circadian rhythms, HNF4A may modulate the core metabolic processes by antagonizing CLOCK:BMAL1-facilitated transcriptional activation.

Discussion {#s8}
==========

Our findings in this study highlight the fundamental roles played by the nuclear receptor HNF4s (including HNF4A and HNF4G) in maintaining the tissue-specific circadian oscillations in the intestinal and liver cells. Similarly, the *Bmal1* activator RORγ, also a nuclear receptor, controls the amplitude of clock genes in peripheral tissues without affecting rhythms in the SCN, where it is not expressed ([@r29], [@r33]). The identification of tissue-specific clock regulators reveals one mechanism generating tissue-specific circadian rhythms and allows precise modulation of clock networks in specific organs.

We report here a noncanonical transrepression activity of HNF4A reminiscent of the antiinflammatory activities of glucocorticoid receptor (GR) that are caused predominantly by regulating the key proinflammatory transcription factors nuclear factor-κB (NF-κB) and activator protein 1 (AP-1). Consistent with our observations here, nuclear receptor GR physically interacts with NF-κB or AP-1 heterodimers and represses their transcriptional activity ([@r70], [@r71]). The exact mechanism by which GR inhibits the proinflammatory factors is still unclear, although several models have been proposed. The chromatin recruitment of GR to the vicinity of the proinflammatory factors could be achieved by "tethering," through the protein--protein interactions. Apart from this, at some promoters, it could also be mediated by a "composite binding" in which GR binding to both the target transcription factor and DNA is required. Afterward, the first mode of GR-mediated transrepression is attributable to a direct repression of the DNA binding and/or transactivation functions of the proinflammatory factors, dependent on the specific physical interactions. In addition, there are indirect modes that may involve competition for limiting amounts of coactivator, recruitment of corepressor, and interference with the basal transcriptional machinery (BTM) ([@r72][@r73]--[@r74]).

Our deletion analysis suggests involvement of the DBD, LBD, and F domains of HNF4A in the transrepression of CLOCK:BMAL1. Similarly, GR DBD and LBD domains are also demonstrated to be required for its transrepression function ([@r75][@r76]--[@r77]). In HNF4A, the C-terminal F domain is known as a repressor region that is responsible for recruitment of corepressor SMRT/NCOR2. The requirement of the F domain may imply a role for corepressor recruitment in the process of CLOCK:BMAL1 inhibition. Taken together, we propose an activity of HNF4A in transrepressing CLOCK:BMAL1, the core positive arm of the molecular clock, and consequently a central role in the maintenance of circadian oscillations. Supporting this model, we observed cooccupancy of HNF4A and CLOCK:BMAL1 at clock genes *Dbp*, *Cry1*, *Cry2*, *Per2*, and *Per3* ([*SI Appendix*, Fig. S11](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental)). An HNF4-binding motif was identified at most of these cooccupied loci, suggesting that throughout the HNF4A-mediated CLOCK:BMAL1 transrepression at these clock genes, the composite binding mode may be at play. Hence, similar to GR, HNF4A may bind to the regulatory regions of the clock genes, transrepressing the cooccupying CLOCK:BMAL1 via physical interactions.

Extensive chromosome colocalization of clock components and tissue-specific TFs have been implied to contribute to the circadian control of metabolic pathways ([@r78], [@r79]). In particular, the liver-lineage determining TF hepatocyte nuclear factor 6 (HNF6) tethers the circadian nuclear receptor Rev-erbα, leading to the repression of target gene and circadian regulation of hepatic lipid metabolism ([@r80], [@r81]). Our findings also suggest HNF4A to be a central regulator in the circadian control of metabolisms, which could be accomplished through activities at two distinct levels, depending on the chromatin environment. First, the extensive cooccupancy of HNF4A and CLOCK:BMAL1 strongly suggest that, apart from the core clock, HNF4A negatively modulates the transcriptional activity of CLOCK:BMAL1 in diverse metabolic pathways ([@r82][@r83]--[@r84]). Further, the circadian expression and genome binding of the nuclear receptor HNF4A itself, particularly at loci not cooccupied by CLOCK:BMAL1, is implied to directly result in the circadian expression of downstream metabolic genes responsible for bile acid synthesis and xenobiotic metabolism. HNF1A, another liver-specific TF that shows robust oscillations at the transcription level most likely due to targeting by HNF4A, potentially serves as another link between circadian regulation and metabolic pathways. Taken together, HNF4A provides an interesting link between the molecular regulation of core clock proteins and the metabolic pathways, a subject for future studies.

Materials and Methods {#s9}
=====================

For details on luciferase assays, circadian assays, co-IP, qPCR, HNF4A ChIP-seq, and data analysis, please see [*SI Appendix*, *SI Materials and Methods*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1816411115/-/DCSupplemental).

All animal care and experiments were performed under the institutional protocols approved by the Institutional Animal Care and Use Committee at the University of Southern California.
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